Skip to main content
. 2020 Jan 21;19:1290–1298. doi: 10.1016/j.omtn.2020.01.012

Figure 1.

Figure 1

SNP Targeting Strategy

(A) SNP heterozygosity across five genetic super populations. See https://www.internationalgenome.org/category/population/ for details on population descriptions. (B) Developing ASOs for individual HCM mutations is not currently a feasible therapeutic strategy. By targeting SNPs, multiple MYH7 disease-causing mutations can be targeted with a single ASO.